CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Anavex Life Sciences Welcomes Dr. Jiong Ma to its Board of Directors

Life Sciences Review Life Sciences Review | Friday, June 04, 2021
Tweet

Jiong Ma is a senior board executive with over 25 years of expertise in investing, growing, and developing businesses, with a focus on new product launches in digital health, technology, and the new energy transition.


FREMONT, CA: Anavex Life Sciences is a clinical-stage biopharmaceutical company developing differentiated therapeutics to treat neurodegenerative and neurodevelopmental disorders such as Alzheimer’s disease, Parkinson’s disease, Rett syndrome, and other CNS diseases announced the appointment of Jiong Ma, Ph.D. to its Board of Directors.


Jiong Ma is a senior board executive with over 25 years of expertise in investing, growing, and developing businesses, with a focus on new product launches in digital health, technology, and the new energy transition. Dr. Jiong Ma is and has been a Board Director of LinkinVax, Aledia, Voxel8, Lo3 Energy, Storiant, Fulham, Convey Computer (acquired by Micron Technology), mc10 (acquired by Medidata), Powervation (acquired by RHOM Semiconductor), Laser Light Engine, and Carbonite, which went public via IPO in 2011 and was subsequently acquired by OpenText in n 2019 for approximately 1.45 billion dollars.


Check Out This : Energy Business Review


“I am excited to welcome Ms. Ma to Anavex’s Board of Directors,” stated Christopher U Missling, Ph.D., President, and Chief Executive Officer, Anavex. “Ms. Ma brings extensive experience in innovative product launches to Anavex. I am confident she will make important contributions to our Board of Directors and towards the commercial development of ANAVEX2-73.”


Check Out This : Renewable Energy Solution Companies In Europe


Jiong Ma focused on investments in industry digitization, resource efficiency, mobility, renewable energy infrastructure, and deeptech as a Partner at Braemar Energy Ventures ($600 million AUM). She served on the firm’s investment committee. She oversaw more than 15 growth-stage investments, emphasizing new product launches, raising funds, negotiating and structuring investments, hiring management teams, and putting together boards.


“It is an honor to join Anavex’s Board of Directors,” said Ms. Ma. “With the focus on neurodegeneration and neurodevelopmental diseases, Anavex is tackling one of the biggest medical challenges that our society faces today. In addition, I am impressed with the breadth of Anavex’s pipeline. I look forward to applying my insights to advance Anavex towards its next stage of growth on the way to commercial success.”


She formerly worked at 3i, a global private equity firm with a $17 billion AUM, where she oversaw investments in Digital Health, TMT, and Cleantech at various phases. Jiong Ma held numerous key positions at Lucent Technologies and Bell Labs before joining 3i’s Venture Capital Group. Furthermore, her responsibilities included product portfolio planning, new product releases for Optical and Data Networking, research and product development, and product portfolio strategy. Jiong Ma was also a member of the founding team of Onetta, a fiber network firm. She holds a doctorate in electrical and computer engineering from the University of Colorado at Boulder and a master’s degree in electrical engineering from Worcester Polytechnic Institute. She has been named a Kauffman Fellow.


Weekly Brief

loading
Top 10 Preeminent Cros – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/anavex-life-sciences-welcomes-dr-jiong-ma-to-its-board-of-directors--nwid-388.html